title: Phase I clinical trial of recombinant human interleukin-3 combined with carboplatin in the treatment of patients with recurrent ovarian carcinoma.
authors: Hamilton Regional Cancer Center, Ontario, Canada.
authors: J J
authors: JJ
authors: Rusthoven
authors: E
authors: E
authors: Eisenhauer
authors: J
authors: J
authors: Mazurka
authors: H
authors: H
authors: Hirte
authors: G
authors: G
authors: O'Connell
authors: A
authors: A
authors: Muldal
authors: H X
authors: HX
authors: Lu
authors: N
authors: N
authors: Onetto
authors: K
authors: K
authors: Swenerton
authors: J
authors: J
authors: Jeffrey
mesh_terms: D016190:Carboplatin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007377:Interleukin-3 / Q000008:administration & dosage* / Q000009:adverse effects; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009504:Neutrophils / Q000187:drug effects; D010051:Ovarian Neoplasms / Q000097:blood / Q000188:drug therapy*; D010976:Platelet Count / Q000187:drug effects; D011994:Recombinant Proteins / Q000008:administration & dosage
chemical_list: D007377:Interleukin-3; D011994:Recombinant Proteins; D016190:Carboplatin